Microalbuminuria as a predictor of clinical diabetic nephropathy.
about
Liver function tests and urinary albumin in house painters with previous heavy exposure to organic solventsTherapeutic Modalities in Diabetic Nephropathy: Future Approaches.Predictors of diabetic renal lesions in type 2 diabetes associated with microalbuminuria.Microalbuminuria among Type 1 and Type 2 diabetic patients of African origin in Dar Es Salaam, Tanzania.Nephropathy in type 2 diabetes.Microalbuminuria is associated with limited joint mobility in type I diabetes mellitusAssessment of urinary protein 1 and transferrin as early markers of cadmium nephrotoxicity.Potential urinary biomarkers of disease activity in Crohn's disease.Soluble Urokinase Receptor and the Kidney Response in Diabetes Mellitus.Microproteinuria in patients with inflammatory bowel disease: is it associated with the disease activity or the treatment with 5-aminosalicylic acid?Aberrant DNA methylation patterns in diabetic nephropathyTests of renal function in patients with quiescent colitis: effects of drug treatment.Renal histological heterogeneity and functional progress in normoalbuminuric and microalbuminuric Japanese patients with type 2 diabetes.Regression of microalbuminuria in type 1 diabetes is associated with lower levels of urinary tubular injury biomarkers, kidney injury molecule-1, and N-acetyl-β-D-glucosaminidase.G-CSF prevents progression of diabetic nephropathy in ratRenal tubular proteinuria and microalbuminuria in diabetic patientsEarly markers of the renal complications of insulin dependent diabetes mellitus.Osteoinductive factor is a novel biomarker for the diagnosis of early diabetic nephropathy.Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria.Type 2 Diabetes Mellitus Is Associated with More Serious Small Intestinal Mucosal Injuries.Non enzymatic glycosylation of IgG and their urinary excretion in patients with diabetic nephropathy.Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers for prevention and treatment of nephropathy associated with type 2 diabetes mellitus.Urinary podocalyxin is an early marker for podocyte injury in patients with diabetes: establishment of a highly sensitive ELISA to detect urinary podocalyxin.High levels of oxidized LDL in circulating immune complexes are associated with increased odds of developing abnormal albuminuria in Type 1 diabetes.Changes of urinary angiotensinogen concentration and its association with urinary proteins in diabetic rats.Relationship between albuminuria and total proteinuria in systemic lupus erythematosus nephritis: diagnostic and therapeutic implications.Prognostic Value of Tubulointerstitial Lesions, Urinary N-Acetyl-β-d-Glucosaminidase, and Urinary β2-Microglobulin in Patients with Type 2 Diabetes and Biopsy-Proven Diabetic Nephropathy.Proteinuria: changes and mechanisms in toxic nephropathies.Baseline markers of inflammation are associated with progression to macroalbuminuria in type 1 diabetic subjectsDiabetic retinopathy and microalbuminuria can predict macroalbuminuria and renal function decline in Japanese type 2 diabetic patients: Japan Diabetes Complications StudyExercise-induced albuminuria vs circadian variations in blood pressure in type 1 diabetesNotoginsenoside R1 attenuates glucose-induced podocyte injury via the inhibition of apoptosis and the activation of autophagy through the PI3K/Akt/mTOR signaling pathway.Urine analysis in microfluidic devices.Increased albumin excretion in diabetes.Position of indapamide, a diuretic with vasorelaxant activities, in antihypertensive therapy.Micro-albuminuria in Ugandan children with sickle cell anaemia: a cross-sectional study.Elevated endogenous digitalis-like substance in hypertensive diabetic patients with a family history of hypertension.Effects of hydrogen-rich water on abnormalities in a SHR.Cg-Leprcp/NDmcr rat - a metabolic syndrome rat model.Assessment of urinary osteopontin in association with podocyte for early predication of nephropathy in diabetic patients.Associations of fractalkine receptor (CX3CR1) and CCR5 gene variants with hypertension, diabetes and atherosclerosis in chronic renal failure patients undergoing hemodialysis.
P2860
Q28383754-5A36731B-E822-4FDA-90E8-6C27CC824637Q30423005-E26CBAD7-30A9-4FFD-B095-85DBB6350F70Q31898275-EF0EB417-7454-414C-93F1-72CAD7880D31Q33269264-A7BB49C0-0E4E-464F-AA31-08CE06980BA0Q33542374-668E4815-8663-41B9-B17B-F3C5A943195CQ33578163-D40C633E-7FBD-4FB2-9F8F-57A246D843DFQ33633966-1BE8E4AC-E067-49AF-843E-9CF2CC8FF7A4Q33638861-F38CE132-5A69-4F78-9D29-A12C8E820CF6Q33741426-195250E5-237D-463D-A137-F3D161902AB1Q33788444-B5CC983A-E4B4-436C-B5FE-F59C179CA2D0Q33904741-CF6A53F0-72D6-4AEE-BD84-67DF0F730322Q34396529-0DFF7348-330D-4621-BAEC-6FD07690CBD9Q34419136-A31D99D4-6864-4A19-8329-74F13C63BD72Q34552269-3C817FF8-82A3-42BD-BE62-390EA5F3AEC6Q35027690-D17038E7-7AD1-4E27-B855-497F55C05D1BQ35624128-7C73413F-7540-4A5D-BBE1-B48A7D537677Q35625921-3967DE6C-E2BF-4FCC-861D-BC1D64A073A0Q35632314-7DE3786F-8B8C-4EDE-8E3E-A525D1227DB4Q35705004-A04AF1BD-B356-4969-9F17-DA3E7E2049C5Q36123785-8AF56FBF-FECA-4362-B6FE-7485F202A54AQ36263437-B10CC157-DD59-4256-8D81-3742827229D1Q36289427-95EFDE1E-28F3-4604-A182-CFC1BAFAE5ABQ36297793-3A8545B3-49B9-4261-A722-00DECF7DD823Q36318280-03BF7DDD-B081-49BF-9582-91280E15EDC7Q36374983-59C3377F-6FAE-4582-9D3C-6AEF30C11A8CQ36736718-D942B494-853C-4981-AABD-DFBFB35ACCD5Q36770851-8801BFC7-A1BC-4F32-96CE-5DA0516C6EF1Q36785836-A31E7308-6C2A-48F6-9A98-73FBA86ADE76Q37022573-6110897B-36B9-4A92-A60C-DF8242A5A991Q37106546-3CE22FCF-BA88-469A-8268-FC4C3CAAF15AQ37658429-AEFD327A-4BD8-40D7-9286-327C7642C2BDQ37713980-A02937A2-9DC2-4921-8023-02926321BF88Q37880636-3836ED2F-1BEA-4745-88A1-7051A7C92FC3Q37906391-82C02ECC-C7D6-428D-96EB-4E9C982C219DQ38020945-9D7D8C5A-F485-41C0-8F63-80D9B6BAD5BFQ38870161-96409BB7-89A3-4D0F-A04E-B54765D31BABQ39243031-00C5BCFD-420B-4253-A418-965A168E6FF8Q39638329-F3631787-9B00-4BDA-B370-FCB270C7DDC2Q39698855-FD65365B-8C42-45C6-B8B2-B1B3C9122ECBQ39818605-1A9A718D-AEF2-4D92-B044-7CBD703F42B8
P2860
Microalbuminuria as a predictor of clinical diabetic nephropathy.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年学术文章
@wuu
1987年学术文章
@zh-cn
1987年学术文章
@zh-hans
1987年学术文章
@zh-my
1987年学术文章
@zh-sg
1987年學術文章
@yue
1987年學術文章
@zh
1987年學術文章
@zh-hant
name
Microalbuminuria as a predictor of clinical diabetic nephropathy.
@en
Microalbuminuria as a predictor of clinical diabetic nephropathy.
@nl
type
label
Microalbuminuria as a predictor of clinical diabetic nephropathy.
@en
Microalbuminuria as a predictor of clinical diabetic nephropathy.
@nl
prefLabel
Microalbuminuria as a predictor of clinical diabetic nephropathy.
@en
Microalbuminuria as a predictor of clinical diabetic nephropathy.
@nl
P356
P1433
P1476
Microalbuminuria as a predictor of clinical diabetic nephropathy.
@en
P2093
Mogensen CE
P2888
P304
P356
10.1038/KI.1987.50
P407
P577
1987-02-01T00:00:00Z